Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Triplew Ltd. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are concentrated in 1 distinct art unit but are assigned to 2 distinct examiners. This concentration within a single art unit suggests a specific technical focus for the company's current biotechnological or pharmaceutical applications.
The busiest examiner, CUTLIFF, YATE KAI RENE, is responsible for 1 pending action. Since the company's 2 pending office actions are split between different examiners within the same art unit, they must adapt their prosecution tactics to different individual styles while maintaining consistency within that single technical group. Practitioners should note that having 2 distinct examiners for the pending office actions means that each case is being reviewed by a different person, requiring a customized approach for every application. The success of these matters will depend on the company's ability to satisfy the requirements of both examiners within the 1 distinct art unit involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 33.3% | +29.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261475 | CRYSTALLIZATION OF HIGH-PURITY MAGNESIUM L-LACTATE | KELLY-O'NEILL, YOLANDA LYNNETTE | 11d overdue |
| 18293759 | PROCESS FOR PRODUCING RECYCLED LACTATE SALT | CUTLIFF, YATE KAI RENE | — |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18293759 | PROCESS FOR PRODUCING RECYCLED LACTATE SALT | CUTLIFF, YATE KAI RENE | — | §103 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18261475 | CRYSTALLIZATION OF HIGH-PURITY MAGNESIUM L-LACTATE | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §103 | Final Rejection | 11d overdue | Pending | Jul 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial